211 related articles for article (PubMed ID: 12427397)
21. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
Contraception; 2006 Oct; 74(4):324-7. PubMed ID: 16982234
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
[TBL] [Abstract][Full Text] [Related]
23. Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.
El Sharkwy IAE; Elsayed ML; Ahmed MA; Alnemer AAA
J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3703-3707. PubMed ID: 29742942
[No Abstract] [Full Text] [Related]
24. Low-dose vaginal misoprostol in the management of intrauterine fetal death.
El-Gharib MN; Elebyary MT
J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1239-42. PubMed ID: 21714693
[TBL] [Abstract][Full Text] [Related]
25. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
Ngai SW; Tang OS; Ho PC
Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and adverse effects of vaginal misoprostol as a single agent for second trimester pregnancy termination: the impact of fetal viability.
Pongsatha S; Suntornlimsiri N; Tongsong T
Arch Gynecol Obstet; 2024 Apr; 309(4):1459-1466. PubMed ID: 37149516
[TBL] [Abstract][Full Text] [Related]
27. Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
Cayrac M; Faillie JL; Flandrin A; Boulot P
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):145-9. PubMed ID: 21511389
[TBL] [Abstract][Full Text] [Related]
28. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination.
Mahjabeen ; Khawaja NP; Rehman R
J Coll Physicians Surg Pak; 2009 Jun; 19(6):359-62. PubMed ID: 19486574
[TBL] [Abstract][Full Text] [Related]
29. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
Zou LY; Fan L
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death.
Chittacharoen A; Herabutya Y; Punyavachira P
Obstet Gynecol; 2003 Jan; 101(1):70-3. PubMed ID: 12517648
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
[TBL] [Abstract][Full Text] [Related]
32. Induction of labor with intravaginal misoprostol versus intracervical dinoprostone.
Ozgür K; Kizilates A; Uner M; Erman O; Trak B
Arch Gynecol Obstet; 1997; 261(1):9-13. PubMed ID: 9451517
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivates.
Wagner N; Abele H; Hoopmann M; Grischke EM; Blumenstock G; Wallwiener D; Kagan KO
Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):75-8. PubMed ID: 21112135
[TBL] [Abstract][Full Text] [Related]
34. Vaginal misoprostol and intravenous oxytocin for success of termination in the second-trimester intrauterine fetal demise: A randomized controlled clinical trial.
Asadi N; Vafaei H; Hessami K; Darabi MH; Kasraeian M; Faraji A; Alavi A; Abdi N; Gissuei A; Roozmeh S; Bazrafshan K; Gharibpour F
J Obstet Gynaecol Res; 2022 Apr; 48(4):966-972. PubMed ID: 35261120
[TBL] [Abstract][Full Text] [Related]
35. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
Dickinson JE; Brownell P; McGinnis K; Nathan EA
Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
[TBL] [Abstract][Full Text] [Related]
36. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety.
Kunwar S; Saha PK; Goel P; Huria A; Tandon R; Sehgal A
Biosci Trends; 2010 Dec; 4(6):351-4. PubMed ID: 21248435
[TBL] [Abstract][Full Text] [Related]
37. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise.
Elhassan EM; Abubaker MS; Adam I
Int J Gynaecol Obstet; 2008 Jan; 100(1):82-3. PubMed ID: 17888920
[No Abstract] [Full Text] [Related]
38. Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
Perritt JB; Burke A; Edelman AB
Contraception; 2013 Sep; 88(3):341-9. PubMed ID: 23756114
[TBL] [Abstract][Full Text] [Related]
39. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
[TBL] [Abstract][Full Text] [Related]
40. Vaginal misoprostol for second-trimester pregnancy termination after one previous cesarean delivery.
Naguib AH; Morsi HM; Borg TF; Fayed ST; Hemeda HM
Int J Gynaecol Obstet; 2010 Jan; 108(1):48-51. PubMed ID: 19781700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
